Clinical Trials
9 trialsNCT05613413 2026-01-08
LUNG-IST-127
University of Illinois at Chicago
Phase 2 Recruiting
NCT01639508 2025-12-17
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT05859217 2024-05-08
Cabatezo-1
University of Kansas Medical Center
Phase 2 Not yet recruiting
NCT02795156 2023-12-05
Study Assessing Activity of Molecularly Matched Targeted Therapies in Select Tumor Types Based on Genomic Alterations
SCRI Development Innovations, LLC
Phase 2 Completed
NCT04173338 2022-06-14
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
Augusta University
Phase 1 Terminated
NCT02132598 2021-03-10
Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases
University of Pittsburgh
Phase 2 Terminated
NCT01588821 2020-09-29
Cabozantinib in Advanced Solid Malignancies
Massachusetts General Hospital
Phase 2 Completed
NCT04131543 2019-10-18
CRETA
University of Bologna
Phase 2 Unknown
NCT03911193 2019-04-11
CABinMET
Fondazione Ricerca Traslazionale
Phase 2 Unknown